Nuveen
NUVB icon

Nuveen’s Nuvation Bio NUVB Stock Holding History

Nuveen’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.16M Buy
1,083,628
+569,511
+111% +$2.78M ﹤0.01% 1975
2026
Q1 		$2.21M Sell
514,117
-2,337,884
-82% -$13M ﹤0.01% 2241
2025
Q4 		$25.6M Sell
2,852,001
-1,714,700
-38% -$10.6M 0.01% 1001
2025
Q3 		$16.9M Buy
4,566,701
+3,081,367
+207% +$8.4M ﹤0.01% 1247
2025
Q2 		$2.9M Buy
1,485,334
+1,031,542
+227% +$2.15M ﹤0.01% 2133
2025
Q1 		$799K Sell
453,792
-1,080,333
-70% -$2.46M ﹤0.01% 2737
2024
Q4 		$4.08M Sell
1,534,125
-46,270
-3% -$119K ﹤0.01% 2073
2024
Q3 		$3.62M Buy
1,580,395
+74,225
+5% +$226K ﹤0.01% 2135
2024
Q2 		$4.4M Buy
1,506,170
+630,808
+72% +$1.92M ﹤0.01% 2019
2024
Q1 		$3.19M Buy
875,362
+466,670
+114% +$896K ﹤0.01% 2179
2023
Q4 		$617K Sell
408,692
-326,712
-44% -$420K ﹤0.01% 2938
2023
Q3 		$985K Sell
735,404
-3,966
-0.5% -$6.6K ﹤0.01% 2581
2023
Q2 		$1.33M Sell
739,370
-53,868
-7% -$91.6K ﹤0.01% 2529
2023
Q1 		$1.32M Buy
793,238
+282,069
+55% +$572K ﹤0.01% 2502
2022
Q4 		$981K Sell
511,169
-64,031
-11% -$130K ﹤0.01% 2685
2022
Q3 		$1.29M Sell
575,200
-12,492
-2% -$35.7K ﹤0.01% 2630
2022
Q2 		$1.9M Buy
587,692
+9,468
+2% +$41.3K ﹤0.01% 2459
2022
Q1 		$3.05M Sell
578,224
-154,885
-21% -$870K ﹤0.01% 2307
2021
Q4 		$6.23M Buy
733,109
+307,748
+72% +$2.83M ﹤0.01% 1989
2021
Q3 		$4.23M Buy
425,361
+174,318
+69% +$1.58M ﹤0.01% 2310
2021
Q2 		$2.34M Buy
+251,043
New +$2.86M ﹤0.01% 2634

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nuveen's NUVB Position: Q2 2026 in Review

Nuveen increased its Nuvation Bio (NUVB) stake by 111% in Q2 2026, buying an estimated $2.78M and bringing the position to 1,083,628 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Nuveen first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $25.6M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Nuveen held 1,083,628 shares of Nuvation Bio worth $6.16M as of Q2 2026.
  • Nuveen bought 569,511 Nuvation Bio shares in Q2 2026, an estimated $2.78M.
  • Nuvation Bio made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1975 holding.
  • Nuveen first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
  • Nuveen's Nuvation Bio position peaked at $25.6M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.